Anti-rejection drug treatment increases basal cell carcinoma burden in Ptchl +/- mice

Journal of Investigative Dermatology

Volumn 124, Issue 1, 2005, Pages 263-267

  Vogt, Annika ^a,c   Hebert, Jennifer ^a   Hwang, Jimmy ^b   Lu, Ying ^b   Epstein Jr , Ervin H ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Basal cell carcinoma; Cyclosporine A; Hedgehog; Organ transplantation; Patched

Indexed keywords

CESIUM 137; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; PROTEIN PATCHED 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL CELL CARCINOMA; GRAFT REJECTION; IMMUNOSUPPRESSIVE TREATMENT; IRRADIATION; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CANCER;

EID: 11944274808     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2004.23573.x     Document Type: Article

References (40)

1. Akiyama T, Imanishi M, Matsuda H, Nishioka T, Kunikata S, Kurita T: Difference among races in posttransplant malignancies: Report from an oriental country. Transplant Proc 30:2058-2059, 1998
2. Aszterbaum M, Epstein J, Oro A, Douglas V, LeBoit PE, Scott MP, Epstein EH Jr: Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice. Nat Med 5:1285-1291, 1999
3. Bavinck JN, Bastiaens MT, Marugg ME, Beckers RC, Westendorp RG, Vermeer BJ, Claas FH: Further evidence for an association of HLA-DR7 with basal cell carcinoma on the tropical island of Saba. Arch Dermatol 136:1019-1022, 2000
4. Bavinck JN, De Boer A, Vermeer BJ, et al: Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients. Br J Dermatol 129:242-249, 1993
5. Berden JH, Faaber P, Assmann KJ, Rijke TP: Effects of cyclosporin A on autoimmune disease in MRL/1 and BXSB mice. Scand J Immunol 24:405-411, 1986
6. Berg D, Otley CC: Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. J Am Acad Dermatol 47:1-17; quiz 18-20, 2002
7. Carroll RP, Ramsay HM, Fryer AA, Hawley CM, Nicol DL, Harden PN: Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: A prospective study in Queensland, Australia. Am J Kidney Dis 41:676-683, 2003
8. Daynes RA, Harris CC, Connor RJ, Eichwald EJ: Skin cancer development in mice exposed chronically to immunosuppressive agents. J Natl Cancer Inst 62:1075-1081, 1979
9. Euvrard S, Kanitakis J, Claudy A: Skin cancers after organ transplantation. N Engl J Med 348:1681-1691, 2003
10. Fortina AB, Caforio AL, Piaserico S, et al: Skin cancer in heart transplant recipients: Frequency and risk factor analysis. J Heart Lung Transplant 19:249-255, 2000
11. Goodrich LV, Milenkovic L, Higgins KM, Scott MP: Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 277:1109-1113, 1997
12. Gottsch JD, Akpek EK: Topical cyclosporin stimulates neovascularization in resolving sterile rheumatoid central corneal ulcers. Trans Am Ophthalmol Soc 98:81-87; discussion 87-90, 2000
13. Green A, Williams G, Neale R, et al: Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: A randomised controlled trial. Lancet 359:723-729, 1999
14. Guba M, von Breitenbuch P, Steinbauer M, et al: Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: Involvement of vascular endothelial growth factor. Nat Med 8:128-135, 2002
15. Gupta S, Fass D, Shimizu M, Vayuvegula B: Potentiation of immunosuppressive effects of cyclosporin A by 1 alpha,25-dihydroxyvitamin D3. Cell Immunol 121:290-297, 1989
16. Hartevelt MM, Bavinck JN, Kootte AM, Vermeer BJ, Vandenbroucke JP: Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 49:506-509, 1990
17. Hebert JL, Khugyani F, Athar M, Kopelovich L, Epstein EH Jr, Aszterbaum M: Chemoprevention of basal cell carcinomas in the ptc1 +/- mouse-green and black tea. Skin Pharmacol Appl Skin Physiol 14:358-362, 2001
18. Herman M, Weinstein T, Korzets A, et al: Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients. J Lab Clin Med 137:14-20, 2001
19. Hojo M, Morimoto T, Maluccio M, et al: Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 397:530-534, 1999
20. Jensen P, Hansen S, Moller B, et al: Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 40:177-186, 1999
21. Kelly GE, Meikle W, Sheil AG: Effects of immunosuppressive therapy on the induction of skin tumors by ultraviolet irradiation in hairless mice. Transplantation 44:429-434, 1987
22. Kelly GE, Meikle WD, Moore DE: Enhancement of UV-induced skin carcinogenesis by azathioprine: Role of photochemical sensitisation. Photochem Photobiol 49:59-65, 1989
23. Koranda FC, Loeffler RT, Koranda DM, Penn I: Accelerated induction of skin cancers by ultraviolet radiation in hairless mice treated with immunosuppressive agents. Surg Forum 26:145-146, 1975
24. Kyllonen L, Salmela K, Pukkala E: Cancer incidence in a kidney-transplanted population. Transpl Int 13:3394-3398, 2000
25. Lindelof B, Sigurgeirsson B, Gabel H, Stern RS: Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 143:513-519, 2000
26. Naldi L, Fortina AB, Lovati S, et al: Risk of nonmelanoma skin cancer in Italian organ transplant recipients. A registry-based study. Transplantation 70:1479-1484, 2000
27. Nathanson RB, Forbes PD, Urbach F: Modification of photocarcinogenesis by two immunosuppressive agents. Cancer Lett 1:243-247, 1976
28. Ong CS, Keogh AM, Kossard S, Macdonald PS, Spratt PM: Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 40:27-34, 1999
29. Otley CC: Immunosuppression and skin cancer: Pathogenetic insights, therapeutic challenges, and opportunities for innovation. Arch Dermatol 138:827-828, 2002
30. Parkin DM, Muir CS: Cancer incidence in five continents. Comparability and quality of data. IARC Sci Publ 120:45-173, 1992
31. Pazzaglia S, Mancuso M, Tanori M, et al: Modulation of patched-associated susceptibility to radiation induced tumorigenesis by genetic background. Cancer Res 64:3798-3806, 2004
32. Penn I: Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl 99-109, 1994
33. Penn I: Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl 147-158, 1998
34. Ramsay HM, Fryer AA, Hawley CM, Smith AG, Harden PN: Non-melanoma skin cancer risk in the Queensland renal transplant population. Br J Dermatol 147:950-956, 2002
35. Ramsay HM, Fryer AA, Reece S, Smith AG, Harden PN: Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis 36:167-176, 2000
36. Reeve VE, Greenoak GE, Gallagher CH, Canfield PJ, Wilkinson FJ: Effect of immunosuppressive agents and sunscreens on UV carcinogenesis in the hairless mouse. Aust J Exp Biol Med Sci 63:655-665, 1985
37. San Jose I, Garcia-Suarez O, Hannestad J, Cabo R, Gauna L, Represa J, Vega JA: The thymus of the hairless rhino-j (hr/rh-j) mice. J Anat Pt 198:399-406, 2001
38. Sugie N, Fujii N, Danno K: Cyclosporin-A suppresses p53-dependent repair DNA synthesis and apoptosis following ultraviolet-B irradiation. Photodermatol Photoimmunol Photomed 18:163-168, 2002
39. Thakur M, Wernick M, Collins C, Limoli CL, Crowley E, Cleaver JE: DNA polymerase eta undergoes alternative splicing, protects against UV sensitivity and apoptosis, and suppresses Mre11-dependent recombination. Genes Chromosomes Cancer 32:222-235, 2001
40. Vogt A, Chuang PT, Hebert J, et al: Immunoprevention of basal cell carcinomas with recombinant hedgehog-interacting protein. J Exp Med 199:753-761, 2004